BSE filing, NSE: REFEX. Summary written from the filing by ALFA Finder's alert engine.
Refex Industries Ltd: key numbers
- Share price
- ₹222.65
- Market cap
- ₹3,055 Cr
- Revenue (annual)
- ₹2,277 Cr
- Net profit (annual)
- ₹203.3 Cr
- P/E (TTM)
- 11.8×Sector 52.2×
- Promoter holding
- 56.56%-0.01% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Refex Industries Ltd
All →Refex Industries Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue ₹559.5 Cr (+36.1%), PAT ₹59.5 Cr (+13.1%); H1 revenue ₹1,178.8 Cr (+54.7%), PAT ₹133.2 Cr (+55.4%). Order book ₹1,721 Cr; RMC and wind ramping.
Refex Industries Results Update
Refex Industries reported Q2FY27 revenue of ₹560 cr (up 36.1% YoY) and PAT of ₹60 cr (up 13.1% YoY). H1FY27 PAT rose 55.4% to ₹133.2 cr.
Refex Industries Q2 FY27 Results: Net Profit ₹50.7 Cr, Up 40.1% YoY
Refex Industries Ltd reported revenue from operations of ₹761.3 Cr (+83.6% YoY) and net profit of ₹50.7 Cr (+40.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹50.7 Cr · +40.1% YoY
Refex Industries Board Meeting Date
Refex Industries has scheduled a board meeting for October 28, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Refex Industries Other Announcement
Refex Industries Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a standard regulatory compliance filing.
Refex Industries Bags ₹31.45 Cr Order from A Maharatna Public Sector Undertaking under the Ministry of Power
Refex Industries won a Rs.31.45 Crore slab-wise rate contract for ash transportation from a Maharatna PSU. The one-year contract, extendable by six months, supports NHAI and PMGSY road projects.
- Value
- ₹31.45 Cr
- From
- A Maharatna Public Sector Undertaking under the Ministry of Power
- Execution
- 1 year, extendable by 6 months
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.